Clearing the Hurdles: Issues and Answers in the Treatment of Metastatic Colorectal Cancer– Colorectal cancer (CRC) is the third most common type of cancer diagnosed among men and women in the United States. Due to improvements in treatment options and earlier detection, mortality rates associated with CRC have decreased over the past two decades. Survival rates for metastatic disease remain extremely low and there is a clinical need for new treatment strategies. Personalization of care has become the goal in treating many forms of cancer and is increasingly being applied to the management of metastatic CRC. The availability of targeted approaches, as well as predictive and prognostic biomarkers, allows care to be individualized in patients with metastatic disease. By using these patient- and tumor-specific characteristics, health care practitioners can select the most appropriate therapy for a patient to maximize outcomes for these most difficult-to-treat forms of CRC.
Explain community, institutional, and regional practice barriers to the optimization of personalized care in the setting of metastatic CRC.
Describe contemporary methods for targeted and chemotherapeutic approaches to manage metastatic CRC in multiple lines of treatment.
Explain how the evolving use of prognostic and predictive biomarkers can be utilized as a method to personalize treatment in patients with metastatic CRC.
Discuss clinical trial data concerning the use of novel strategies for the management of metastatic CRC in the front-line setting.
Apply clinical trial evidence to the management of patients with metastatic CRC in the front-line treatment setting.
1.0 Free CEUs for Nurses
This course also offers Free CME for Physicians